By Conjoint Professor David goldstein

Book Chapters

Kokkinos J; Sharbeen G; Phillips PA, 2024, 'Management of Primary Pancreatic Cancer', in Jankowski JAZ (ed.), Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach, Wiley, pp. 386 - 406, http://dx.doi.org/10.1002/9781119756422.ch20

Butow P; Tattersall MHN; Clayton J; Goldstein D, 2013, 'Breaking bad news and truth disclosure in Australia', in New Challenges in Communication with Cancer Patients, pp. 377 - 387, http://dx.doi.org/10.1007/978-1-4614-3369-9_31

Goldstein D; Jones R; Smalley RV; Borden EC, 2010, 'Interferon Therapy and Cancer', in Oldham RK (ed.), Cancer Biotherapy: Principles and Practice, Springer, New York, pp. 277 - 302

Yip D; Karapetis C; Strickland A; Steer C; Goldstein D; Harper P, 2000, 'Chemotherapy and radiotherapy for pancreatic cancer', in Yip D (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd002093

Smalley RV; Goldstein D; Borden EC, 1998, 'Interferons: Therapy in Cancer', in Principles of Cancer Biotherapy, Springer Netherlands, pp. 266 - 283, http://dx.doi.org/10.1007/978-94-009-0029-5_11

Journal articles

Chiang S; Garcia Netto K; Kokkinos J; Haghighi KS; Raina AS; Youkhana J; Pitiyarachchi O; Truong Q; Wenholz D; Wilkinson J; Laczka O; Li X; Aldilla VR; Kumar N; Goldstein D; Sharbeen G; Phillips PA, 2025, 'CRO-67 has anti-cancer activity in pancreatic tumor cells and stromal cancer-associated fibroblasts', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-09411-2

Liang S; Kennedy E; Gale N; Watson P; Ramanathan M; Shinde A; McKay S; Torres-Robles A; Li Z; Chan J; Jones H; Ballinger ML; Butow P; Goldstein D; Leaney K; Middleton S; Morrow A; Thomas DM; Tucker KM; Zaheed M; Parkinson B; Lin F; Taylor N, 2025, 'Implementation of precision medicine in treating non-communicable diseases: a systematic review', Journal of Translational Medicine, 23, http://dx.doi.org/10.1186/s12967-025-07201-y

Liang S; McKay S; Lin F; Zaheed M; Morrow A; Douglas B; Chan J; Monaghan H; Chan P; Kennedy E; Tyedmers E; Walker S; Leaney K; Napier CE; Middleton S; Butow P; Williams R; Parkinson B; Ballinger ML; Tucker K; Goldstein D; Thomas D; Taylor N, 2025, 'Integration of precision medicine into routine cancer care—protocol for the Precision Care Initiative: a research programme of effectiveness-implementation hybrid trials', BMJ Open, 15, http://dx.doi.org/10.1136/bmjopen-2024-090270

Shammas-Toma M; Sampieri G; Xie M; Maxwell A; Esemezie A; Pham Q; Cafazzo JA; Wong P; Tsai CJ; Goldstein DP; de Almeida JR; Sejdic E; Yao CMKL, 2025, 'Wearable Technologies in Head and Neck Oncology: Scoping Review', Jmir Mhealth and Uhealth, 13, pp. e72372, http://dx.doi.org/10.2196/72372

Maharaj AD; Brown B; Evans H; Evans SM; Ioannou LJ; Earnest A; Croagh D; Pilgrim CH; Greenhill E; Neale RE; Goldstein D; Kench JG; Merrett ND; White K; Haghighi KS; Samra JS; Zalcberg JR, 2025, 'Aiming for high quality of care for completed resections and improved margin status in pancreatic cancer surgery.', Pancreatology, http://dx.doi.org/10.1016/j.pan.2025.09.029

Sajisevi M; Nguyen K; Callas P; Holcomb AJ; Vural E; Davis KP; Thomas CM; Stein JS; Asarkar A; Aulet R; Bell RK; Blasco MA; Bowmaster VB; Burruss CP; Chung J; Chan K; Chang BA; Coffey CS; Cognetti DM; Cooper DJ; Cordero J; Donovan J; Du YJ; Dundar Y; Dedivitis R; Edwards H; Erovic BM; Eskander A; Feinberg PA; Garvey EA; Goldstein D; Goodman JF; Goulart RN; Goyal N; Grasl S; Giurintano J; Gupta N; Habib A; Hackman T; Hara JH; Henson C; Hinni ML; Hua N; Johnson-Obaseki S; Juloori A; Kalman NS; Kejner A; Khaja SF; Ku JA; Lambert A; Luu BK; Magliocca KR; Medina dos Santos LR; Michael C; Miles B; de Melo GM; Moore MG; Morand GB; Moura K; Noroozi H; Patel R; Paydarfar J; Plonowska-Hirschfeld KA; Sadeghi N; Savaria F; Schmitt NC; Shapiro J; Shaver TB; Stoeckli SJ; Stokes WA; Sulibhavi A; Tasoulas J; Vendra V; Vinh DB; Virgen CG; Woody NM; Young GD; Kakarala K; Enepekides DJ; Hier MP; Davies L; Ryan WR, 2025, 'Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study', Laryngoscope Investigative Otolaryngology, 10, http://dx.doi.org/10.1002/lio2.70246

Mathew JM; Ringash J; Su J; Levin W; Bratman S; Cho BCJ; Hahn E; Abdalaty AH; Hope A; Kim J; McPartlin A; O'Sullivan B; Tsai CJ; Waldron J; Spreafico A; Goldstein D; Woodside M; Cruz DJ; Parmelee S; Kwan JYY; Huang SH; Wong P, 2025, 'Risk factors and survival impact of severe radiation-related late toxicities in head and neck cancer–a cohort study', Lancet Regional Health Americas, 50, http://dx.doi.org/10.1016/j.lana.2025.101218

Sharbeen G; Youkhana J; Netto KG; Raina AS; Chiang S; Haghighi KS; Kokkinos J; Pitiyarachchi O; Yang J; Wang T; Swarbrick A; Goldstein D; Phillips PA, 2025, 'Assessing the response of 3D human pancreatic tumor explants to standard chemotherapy', CANCER RESEARCH, 85, pp. B80 - B80, http://dx.doi.org/10.1158/1538-7445.PANCREATIC25-B080

Schulstad G; Kokkinos J; Youkhana J; Raina AS; Davis ME; Arkell OSM; Netto KG; Boyer C; Goldstein D; Haghighi KS; Sharbeen G; McCarroll JA; Phillips PA, 2025, 'βIII-tubulin is a dual cell therapeutic target in pancreatic cancer and regulates sensitivity to TRAIL through a DR5-dependent mechanism', CANCER RESEARCH, 85, pp. A67 - A67, http://dx.doi.org/10.1158/1538-7445.PANCREATIC25-A067

Lui RN; Billod J; Frentzas S; Hoang H; Eaton V; Lei XJ; Garrett-Mayer E; Goldstein D; Dent R; Chua MLK, 2025, 'Understanding Barriers to Clinical Cancer Research in the Asia-Pacific', JCO Global Oncology, 11, pp. e2500145, http://dx.doi.org/10.1200/GO-25-00145

Michael M; Wong R; Gill S; Strickland AH; Pavlakis N; Shapiro JD; Link E; Farrell M; Ngan SY; Tie J; Heriot AG; Goldstein D; Mitchell C; Roth S; Wilson K; Mui M; Ramsay RG; Segelov E, 2025, 'The Ave–Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer', Clinical Cancer Research, 31, pp. 3452 - 3462, http://dx.doi.org/10.1158/1078-0432.CCR-25-0705

Moharrami M; Watson E; Huang SH; Madathil S; Kim J; McPartlin A; Malik NH; Singhal S; Tsai CJ; Waldron J; Bratman S; Hope A; de Almeida J; Yao CM; Goldstein D; Quinonez C; Glogauer M; Hosni A, 2025, 'Defining the optimal radiation thresholds for Stratifying jaw osteoradionecrosis risk in head and neck cancer', Radiotherapy and Oncology, 209, http://dx.doi.org/10.1016/j.radonc.2025.110996

Soon YY; Sjoquist K; Marschner IC; Schou IM; Pavlakis N; Goldstein D; Shitara K; Stockler MR; Simes J; Martin AJ, 2025, 'INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curse', Jnci Cancer Spectrum, 9, http://dx.doi.org/10.1093/jncics/pkaf053

Zahid Hosen SM; Kumar AA; Xu Z; Mekapogu AR; Perera C; Pang T; Pirola R; Wilson J; Goldstein D; Buckley BJ; Kelso MJ; Ranson M; Apte M, 2025, 'Selective Urokinase Inhibition Plus Chemotherapy: A Novel Approach to Pancreatic Cancer Treatment via Enhanced Antitumor Immunity and Decreased Metastasis.', Gastroenterology, http://dx.doi.org/10.1053/j.gastro.2025.07.021

Heinrich MC; Blay JY; Gelderblom H; George S; Schöffski P; von Mehren M; Zalcberg JR; Jones RL; Kang YK; Razak AA; Trent J; Attia S; Le Cesne A; Boye K; Goldstein D; Sánchez C; Siontis BL; Cox P; Davis E; Sherman ML; Ruiz-Soto R; Bauer S, 2025, 'Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE', Journal of Clinical Oncology, 43, pp. 2239 - 2244, http://dx.doi.org/10.1200/JCO-24-02818

Sousa MS; Garcia MV; Blanchard M; Daveson B; Currow D; Khan NN; Goldstein D; Findlay M; Landers A; Agar MR, 2025, 'Navigating pain and appetite challenges in palliative care for pancreatic cancer: insights from a national, longitudinal consecutive cohort study', Supportive Care in Cancer, 33, http://dx.doi.org/10.1007/s00520-025-09402-z

Ephraums J; Youkhana J; Raina AS; Schulstad G; Croft K; Mawson A; Kokkinos J; Gonzales-Aloy E; Ignacio RMC; McCarroll JA; Boyer C; Goldstein D; Pajic M; Haghighi KS; Johns A; Gill AJ; Erkan M; Initiative (APGI) APCG; Phillips PA; Sharbeen G, 2025, 'MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability', Neoplasia United States, 61, http://dx.doi.org/10.1016/j.neo.2025.101138

Biesma NC; Graus MUJE; Cirkel GA; Besselink MG; de Groot JWB; Koerkamp BG; Herbschleb KH; Los M; Verdonk RC; Wilmink JW; Cervantes A; Valle JW; Valkenburg-van Iersel LBJ; Froeling FEM; Molenaar IQ; Daamen LA; de Vos-Geelen J; van Santvoort HC; Bockorny B; Carrato A; Chen L; Coveler AL; Dajani O; Diaz LA; El-Rayes BF; Goldstein D; Halfdanarson TR; Hosein PJ; Kim EJ; Liang T; Melisi D; Pruijt JFM; Santoro A; Verschoor AJ; van Voorthuizen T, 2025, 'Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study', European Journal of Surgical Oncology, 51, http://dx.doi.org/10.1016/j.ejso.2024.109544

Bonazzi VF; Aoude LG; Brosda S; Bradford JJ; Lonie JM; Loffler KA; Gartside MG; Patel K; Mukhopadhyay P; Keane C; Gebski V; Kench JG; Goldstein D; Waddell N; Barbour AP, 2025, 'C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients', Asia Pacific Journal of Clinical Oncology, 21, pp. 77 - 86, http://dx.doi.org/10.1111/ajco.13993

Pavlakis N; Shitara K; Sjoquist K; Martin A; Jaworski A; Tebbutt N; Bang YJ; Alcindor T; O'Callaghan C; Strickland A; Rha SY; Lee KW; Kim JS; Bai LY; Hara H; Oh DY; Yip S; Zalcberg J; Price T; Simes J; Goldstein D, 2025, 'INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer', Journal of Clinical Oncology, 43, pp. 453 - 463, http://dx.doi.org/10.1200/JCO.24.00055

Manojlovic-Kolarski M; Su S; Weinreb I; Calvisi R; Perez-Ordonez B; Smith S; Patel S; Valero C; Xu B; Ghossein R; Katabi N; Clark J; Low TH; Gupta R; Graboyes E; Davies J; Richardson M; Goldstein D; Huang SH; O'sullivan B; Xu W; Hansen A; De Almeida JR, 2025, 'Adjuvant Chemoradiotherapy for Oral Cavity SCC With Minor and Major Extranodal Extension', JAMA Otolaryngology Head and Neck Surgery, http://dx.doi.org/10.1001/jamaoto.2025.1721

Trinh T; Au K; Krishnan AV; Timmins HC; Li T; Grimison P; Goldstein D; Park SB, 2025, 'Comparison of nab-paclitaxel, paclitaxel, and oxaliplatin-induced peripheral neuropathy: a cross-sectional cohort study', Acta Oncologica, 64, pp. 527 - 533, http://dx.doi.org/10.2340/1651-226X.2025.42935

Naher SK; Espinoza D; Grimison P; Shitara K; Pavlakis N; Goldstein D; Stockler MR; Mercieca-Bebber R; Sjoquist KM, 2025, 'Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials', Gastric Cancer, http://dx.doi.org/10.1007/s10120-025-01654-2

Martin AJ; Soon YY; Sjoquist KM; Pavlakis N; Goldstein D; Shitara K; Simes JR, 2025, 'Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials', Gastric Cancer, http://dx.doi.org/10.1007/s10120-025-01670-2

Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Monteiro E; Chung J; Su J; Xu W; Esemezie AO; Jones JM; Gafni A; Baxter NN; Goldstein DP, 2025, 'Long-Term Durability of Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer', JAMA Surgery, http://dx.doi.org/10.1001/jamasurg.2025.2957

Gau M; Su J; Huang SH; Alfaraj FA; Olson R; Marta GN; Kowalski LP; Kohler HF; de Matos LL; Moraes FY; Xu W; Sanz-Garcia E; Hahn E; Kim JJ; McPartlin A; O'Sullivan B; Tsai CJ; Waldron J; Prisman E; Irish JC; Yao CMKL; de Almeida JR; Goldstein DP; Hope A; Hosni A, 2025, 'Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective Analysis', International Journal of Radiation Oncology Biology Physics, http://dx.doi.org/10.1016/j.ijrobp.2025.09.011

Hong X; Quimby AE; Mavedatnia D; Pickett AT; Corsten M; Zhang T; Tohme A; Johnson-Obaseki S; Khalil C; Khoury M; Eskander A; Noroozi H; Goldstein D; De Almeida J; Fowler J; MacNeil SD; Nichols AC; Dort J; Hart R; Matthews W; Christopoulos A; Dayan G; Bahig H; Hier MP; Sultanem K; Morand GB; Routhier-Chevrier B; Zhang ZS; Belzile M; Laref H; Olivier MJ; Maniakas A, 2025, 'Oral Cavity Squamous Cell Carcinoma in Young Patients: A Multi-Institutional Study of the Canadian Head & Neck Collaborative Research Initiative', Journal of Otolaryngology Head Neck Surgery Le Journal D Oto Rhino Laryngologie Et De Chirurgie Cervico Faciale, 54, pp. 19160216251351562, http://dx.doi.org/10.1177/19160216251351562

Tzelnick S; Metser U; Yu E; Yao CMKL; Goldstein D; Weinreb I; Perez-Ordonez B; Tsai J; Hosni A; Huang SH; Bratman S; Kim J; de Almeida JR, 2025, 'PET-CT Test Properties for HPV Positive Unknown Primary of the Neck: A FIND Trial Correlative Study', Head and Neck, http://dx.doi.org/10.1002/hed.28238

Stefanovic M; Hernando-Calvo A; Castro JB; Huang SH; Su J; O'Sullivan B; Ringash J; Galiana IL; Borbalas AL; Cirauqui BC; Hahn E; Teruel I; de Almeida JR; Querol JM; Witterick IJ; Rubió-Casadevall J; Goldstein DP; Siu LL; Waldron J; Oliva M; Spreafico A, 2025, 'Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis', Laryngoscope, http://dx.doi.org/10.1002/lary.70044

Li T; Goldstein D; Park SB, 2025, 'What you measure matters: The importance of outcome measures in evaluating the prevalence of painful chemotherapy-induced peripheral neuropathy', Regional Anesthesia and Pain Medicine, http://dx.doi.org/10.1136/rapm-2025-106586

Naher SK; Espinoza D; Grimison PS; Shitara K; Pavlakis N; Goldstein D; Stockler MR; Mercieca-Bebber R; Sjoquist K, 2025, 'Development and validation of a prognostic model for advanced gastric and oesophageal carcinoma (AGOC) using individual patient data from two clinical trials.', JOURNAL OF CLINICAL ONCOLOGY, 43, pp. 499 - 499, http://dx.doi.org/10.1200/JCO.2025.43.4_suppl.499

Lin FP-Y; Goldstein D; Grady JP; Napier C; Thavaneswaran S; Pitiyarachchi O; Kansara M; Chantrill LA; Sjoquist K; Thornton K; Raina A; Magenau A; Simes J; Ballinger ML; Sharbeen G; Timpson P; Pajic M; Phillips P; Thomas DM, 2025, 'Genomic and outcome analysis of recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC) receiving systemic therapy: Results from the Australian MoST and CaSP screening programs.', Journal of Clinical Oncology, 43, pp. 4120 - 4120, http://dx.doi.org/10.1200/jco.2025.43.16_suppl.4120

Joda M; Li T; Timmins HC; Goldstein D; Kiernan MC; Park SB, 2025, 'Identification of axonal degeneration in paclitaxel-treated patients utilising neurophysiological and blood based biomarkers', Clinical Neurophysiology, 176, pp. 2110928 - 2110928, http://dx.doi.org/10.1016/j.clinph.2025.2110928

Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; Friedlander M; Marx G; Boyle F; Wyld D; Henderson R; King T; Baron-Hay S; Kiernan MC; Barnes EH; Goldstein D; Park SB, 2025, 'Risk factors for dose-limiting, chronic and severe chemotherapy-induced peripheral neuropathy', Clinical Neurophysiology, 176, pp. 2110921 - 2110921, http://dx.doi.org/10.1016/j.clinph.2025.2110921

Tzelnick S; de Almeida JR; Yao CMKL; Kibel S; Kuehne N; Grewal R; Butler MO; Saibil S; Spreafico A; Easson A; Goldstein DP, 2024, 'Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure', Laryngoscope, 134, pp. 4292 - 4297, http://dx.doi.org/10.1002/lary.31515

Best MC; Butow P; Savard J; Newson AJ; Campbell R; Vatter S; Napier CE; Bartley N; Tucker K; Ballinger ML; Thomas DM; Juraskova I; Schlub T; Davies G; Meiser B; Goldstein D, 2024, 'From ownership to custodianship of tumor biopsy tissue in genomic testing: A mixed methods study of patient views', Oncologist, 29, pp. e1169 - e1179, http://dx.doi.org/10.1093/oncolo/oyae074

Li T; Timmins HC; Mahfouz FM; Trinh T; Mizrahi D; Horvath LG; Harrison M; Grimison P; Friedlander M; Marx G; Boyle F; Wyld D; Henderson R; King T; Baron-Hay S; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy', JAMA Network Open, 7, pp. e2424139, http://dx.doi.org/10.1001/jamanetworkopen.2024.24139

Niederberger M; Schifano J; Deckert S; Hirt J; Homberg A; Köberich S; Kuhn R; Rommel A; Sonnberger M; Alam M; Backman C; Banno M; Bartoszko J; Bloomfield F; Bober MB; Chalkoo M; Chan TM; Chen Y; Coscia C; de Luca K; Demartines N; Farzandipour M; Goldstein D; Goodman C; Grant S; Hübner M; Harris T; Howell M; Huber AM; Jansen TL; Johnson N; Julious SA; Kenny GP; Konge L; Kopkow C; LaPrade RF; Lim M; Loudovici-Krug D; Ma Y; MacLennan S; Mokkink LB; Montero M; Myles PS; Nayahangan LJ; Pace NL; Page MJ; Parente F; Payne K; Petrovic M; Sprung CL; Raveendran K; Roller-Wirnsberger R; Sconfienza LM; Spinelli A; van der Heijde D; Vohra S; Weissman JS; Westby M; Wu Y; Yadlapati R; Yarris LM; Zhang X, 2024, 'Delphi studies in social and health sciences—Recommendations for an interdisciplinary standardized reporting (DELPHISTAR). Results of a Delphi study', Plos One, 19, http://dx.doi.org/10.1371/journal.pone.0304651

Duguet-Armand M; Su J; OSullivan B; de Almeida J; Hosni A; Weinreb I; Perez-Ordonez B; Smith S; Witterick I; Yao C; Goldstein D; Hope A; Hahn E; Waldron J; Ringash J; Spreafico A; Yu E; Huang SH, 2024, 'Radiology-Pathology Concordance and Prognostication of Nodal Features in pN plus Oral Cavity Cancer', LARYNGOSCOPE, http://dx.doi.org/10.1002/lary.31578

De Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J, 2024, 'Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial', JAMA Otolaryngology Head and Neck Surgery, 150, pp. 463 - 471, http://dx.doi.org/10.1001/jamaoto.2024.0423

Li T; Timmins HC; Mahfouz FM; Mizrahi D; Horvath L; Harrison ML; Grimison PS; Friedlander M; Marx GM; Boyle FM; Wyld D; Henderson R; King T; Baron-Hay SE; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016

Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB, 2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5

Yeung N; Li T; Lin HM; Timmins HC; Goldstein D; Harrison M; Friedlander M; Mahon KL; Giles C; Meikle PJ; Park SB; Horvath LG, 2024, 'Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy', JCO Precision Oncology, 8, http://dx.doi.org/10.1200/PO.23.00690

Mahfouz FM; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; Marx G; Goldstein D; Park SB, 2024, 'Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity', Jnccn Journal of the National Comprehensive Cancer Network, 22, pp. 108 - 116, http://dx.doi.org/10.6004/jnccn.2023.7083

Mahfouz FM; Li T; Joda M; Harrison M; Kumar S; Horvath LG; Grimison P; King T; Goldstein D; Park SB, 2024, 'Upper-limb dysfunction in cancer survivors with chemotherapy-induced peripheral neurotoxicity', Journal of the Neurological Sciences, 457, http://dx.doi.org/10.1016/j.jns.2023.122862

Back to profile page